Product Information
LOPRESSOR 50 MG TABLET is a brand product labeled by Validus Pharmaceuticals LLC, priced at $2.4163 per EA under NDC 30698045801. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the metoprolol tartrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Validus Pharmaceuticals LLCNDC
30698045801
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
1/21/2026
Active Ingredients
METOPROLOL TARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA017963FDA Approved
Before 1982
TE Code
AB
On Market Since
5/5/2014
Pharmacological Classes
Price Statistics
The NADAC for LOPRESSOR 50 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.4163 per EA |
|---|---|
| All-time high | $2.4214 (Oct 16, 2024) |
| All-time low | $2.4135 (Apr 17, 2024) |
| 52-week high | $2.4165 |
| 52-week low | $2.4163 |
| Median price | $2.4196 |
| Average price | $2.4184 |
| Largest weekly change | +0.3% (May 22, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Validus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
metoprolol tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOPRESSOR 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LOPRESSOR 50 MG TABLET, manufactured by Validus Pharmaceuticals LLC, is $2.4163 per EA (NDC 30698045801), effective Sep 30, 2026.
How has the price of LOPRESSOR 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for LOPRESSOR 50 MG TABLET has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LOPRESSOR 50 MG TABLET?
Since Apr 17, 2024, the NADAC for LOPRESSOR 50 MG TABLET has ranged from a low of $2.4135 (Apr 17, 2024) to a high of $2.4214 (Oct 16, 2024), with a median of $2.4196 per EA.
Are there cheaper alternatives to LOPRESSOR 50 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL TARTRATE 50 MG TAB, is $0.0185 per EA — about 99% below LOPRESSOR 50 MG TABLET.
Who manufactures LOPRESSOR 50 MG TABLET?
LOPRESSOR 50 MG TABLET (NDC 30698045801) is labeled by Validus Pharmaceuticals LLC, and CMS classifies it as a brand product.